PROFARMA (Brazil) Today

Equity ratings for PROFARMA ON NM are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of July 2022 and ending today, the 19th of August 2022. Click here to learn more.
PROFARMA ON NM cannot be verified against its exchange. Apparently, PROFARMA is not available for investing at the moment. Please verify the symbol is currently traded on Sao Paolo Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

PROFARMA Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. PROFARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding PROFARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
PROFARMA ON NM is not yet fully synchronised with the market data
PROFARMA ON NM has some characteristics of a very speculative penny stock
PROFARMA ON NM has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported the revenue of 4.51 B. Net Loss for the year was (12.68 M) with profit before overhead, payroll, taxes, and interest of 680.91 M.
PROFARMA ON NM has accumulated about 228.13 M in cash with (31.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.86.
ChairmanSammy Birmarcker
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of PROFARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
PROFARMA ON NM (PFRM3) is traded on Sao Paolo Stock Exchange in Brazil and employs 6,327 people. The company currently falls under 'Small-Cap' category with current market capitalization of 539.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PROFARMA's market, we take the total number of its shares issued and multiply it by PROFARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. PROFARMA ON NM operates under Healthcare sector and is part of Medical Distribution industry. The entity has 122.61 M outstanding shares. PROFARMA ON NM has accumulated about 228.13 M in cash with (31.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.86.
Check PROFARMA Probability Of Bankruptcy

PROFARMA Stock Against Markets

Picking the right benchmark for PROFARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in PROFARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for PROFARMA is critical whether you are bullish or bearish towards PROFARMA ON NM at a given time.
PROFARMA ON NM cannot be verified against its exchange. Apparently, PROFARMA is not available for investing at the moment. Please verify the symbol is currently traded on Sao Paolo Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

PROFARMA Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PROFARMA stock to make a market-neutral strategy. Peer analysis of PROFARMA could also be used in its relative valuation, which is a method of valuing PROFARMA by comparing valuation metrics with similar companies.
ITAUUNIBANCOPN N1WELLS FARGO DRNBERKSHIRE DRNAMAZON DRNVALE ON NMBRASKEM PNB N1COSAN ON NMPFIZER DRNAmn Healthcare ServicesTwist Bioscience CorpFreedom Holding CorpKEURIG DR PEPPERGx Nasdaq-100 CoveredFranklin Mutual EuropeanGARDNER DENVER INC
 Risk & Return  Correlation

PROFARMA Corporate Directors

PROFARMA corporate directors refer to members of a PROFARMA board of directors. The board of directors generally takes responsibility for the PROFARMA's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of PROFARMA's board members must vote for the resolution. The PROFARMA board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Armando Martins - DirectorProfile
Fernando Perrone - Independent DirectorProfile
Maximiliano Fischer - CFO, Director of Investor Relations, Member of the Executive BoardProfile
Dan Ioschpe - Independent DirectorProfile

Invested in PROFARMA ON NM?

You need to understand the risk of investing before taking a position in PROFARMA. The danger of trading PROFARMA ON NM is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of PROFARMA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than PROFARMA. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile PROFARMA ON NM is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center. Note that the PROFARMA ON NM information on this page should be used as a complementary analysis to other PROFARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Tools for PROFARMA Stock

When running PROFARMA ON NM price analysis, check to measure PROFARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PROFARMA is operating at the current time. Most of PROFARMA's value examination focuses on studying past and present price action to predict the probability of PROFARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move PROFARMA's price. Additionally, you may evaluate how the addition of PROFARMA to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go